Companies / Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

Nasdaq: TDACCIK 1926599NEW YORK, NY

Financials

Revenueโ€”
Net income$6.36M
Total debtโ€”
Cash$24.6K
Diluted EPSโ€”
Shares outstanding21.9M

Ownership

21.9M shares outstanding ยท as of May 15, 2026
73.9%Institutions
Ownership
78.7%Class A
Share classes
Class A78.74%
Class B21.26%
Institutions73.92%16,193,027
Public float26.08%5,714,473

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all โ†’
Insider% of sharesShares
Hoffman Michael BCEOChairman and CEO ยท Director
โ€”โ€”

Institutional holders 45

View all โ†’
HolderValue% of shares
Magnetar Financial LLC$13.73M5.93%
Wolverine Asset Management, LLC$13.21M5.71%
AQR Arbitrage LLC$11.55M4.99%
LMR Partners LLP$8.39M3.65%
Hudson Bay Capital Management LP$6.86M2.97%
First Trust Alternative Opportunities Fund$6.82M2.97%
Tenor Capital Management Company, L.P.$6.72M2.90%
Karpus Management, Inc.$6.37M2.75%
Polar Asset Management Partners Inc.$6.35M2.74%
Linden Advisors LP$6.34M2.74%
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ฮ”Position afterImpact
May 27, 2026Hoffman Michael B
CEO
BuyWarrantsโ€”+53K
53,395
0.24% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Linden Capital L.P.Passive13Gโ€”โ€”โ€”

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TDACโ€”โ€”G9008W105โ€”